The measles virus attacks long-lived immune cells, reducing antibody-mediated protection from other infectious diseases and ...

An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...

Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, ...

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...